Literature DB >> 12601753

Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.

Hans Hsienhong Lin1, Li-Yu Wang, Chi-Tan Hu, Shih-Che Huang, Lu-Chin Huang, Sherry S J Lin, Yu-Ming Chiang, Tso-Tsai Liu, Chien-Lin Chen.   

Abstract

Taiwan was an endemic area for hepatitis B virus (HBV) infection, and related liver diseases cause a significant drain of public resources. To control the endemic, a nation-wide newborn vaccination program was started in 1985. We reviewed the results of the annual survey for HBV surface antigen (HBsAg) performed in freshmen class of two high schools in Hualien, eastern Taiwan, from 1991 to 2001. A total of 10,194 students, most of them 15 years old, were tested for serum HBsAg using enzyme immunoassays. There is a significant trend (P < 0.0001) of decreasing HBsAg carrier rate from 20.3 to 4.4% in males and 14.3% to 2.4% in females, respectively, over 11 years. The HBsAg carrier rate was 16.0-20.3% in students surveyed during 1991-1993 (born more than 6 years before the start of the national vaccination program), which decreased to 7.7-11.9% during 1994-1999 (born 1-6 years before the program). It further declined to 4.7% and 3.4% in 2000 and 2001 (born after the start of the program). The HBsAg carrier rate in male students was significantly higher than that in female students in most of the years. The HBV newborn vaccination program not only successfully prevented most of the perinatal transmission of HBV but also reduced horizontal transmission of HBV to children born up to 6 years before the start of the program. Also, the protection persisted for at least 15 years. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601753     DOI: 10.1002/jmv.10333

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan.

Authors:  Hui-Chen Wu; Qiao Wang; Lian-Wen Wang; Hwai-I Yang; Habibul Ahsan; Wei-Yann Tsai; Li-Yu Wang; Shu-Yuan Chen; Chien-Jen Chen; Regina M Santella
Journal:  Cancer Lett       Date:  2007-01-23       Impact factor: 8.679

2.  Lay beliefs about hepatitis among North American Chinese: implications for hepatitis prevention.

Authors:  Hueifang Chen; Shin-Ping Tu; Chong Z Teh; Mei-Po Yip; John H Choe; T Gregory Hislop; Victoria M Taylor; Beti Thompson
Journal:  J Community Health       Date:  2006-04

3.  24 year outcomes of hepatitis B vaccination in Hangzhou, China.

Authors:  Jian Du; Yuyang Xu; Jun Wang; Shijun Liu; Yan Liu; Xiaoping Zhang; Erping Xu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Three decades of hepatitis B control with vaccination.

Authors:  Liliane C Meireles; Rui Tato Marinho; Pierre Van Damme
Journal:  World J Hepatol       Date:  2015-08-28

5.  Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents.

Authors:  Tzu-Wei Wu; Chen-Chung Chu; Tzu-Ying Ho; Huei-Wen Chang Liao; Sheng-Kai Lin; Marie Lin; Hans Hsienhong Lin; Li-Yu Wang
Journal:  Hum Genet       Date:  2013-06-06       Impact factor: 4.132

6.  Hepatitis B virus translocates across a trophoblastic barrier.

Authors:  Purnima Bhat; David A Anderson
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

7.  Comparison of long-term immunogenicity (23 years) of 10 μg and 20 μg doses of hepatitis B vaccine in healthy children.

Authors:  Qian Wu; Gui-hua Zhuang; Xue-liang Wang; Tie-jun Hou; Dimpy P Shah; Xiao-li Wei; Li-rong Wang; Min Zhang
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

8.  Emerging infectious determinants of chronic diseases.

Authors:  Siobhán M O'Connor; Christopher E Taylor; James M Hughes
Journal:  Emerg Infect Dis       Date:  2006-07       Impact factor: 6.883

9.  Recent trends in hepatitis B virus infection in the general Korean population.

Authors:  Hyuck Kim; A Ri Shin; Hoe Hoon Chung; Min Kyoung Kim; Ji Sung Lee; Jae-Jun Shim; Byung-Ho Kim
Journal:  Korean J Intern Med       Date:  2013-07-01       Impact factor: 2.884

10.  Chronic hepatitis B in Korean Americans: decreased prevalence and poor linkage to care.

Authors:  Chul S Hyun; Sue Kim; Seung Y Kang; Seo Jung; Seulgi Lee
Journal:  BMC Infect Dis       Date:  2016-08-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.